{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:16:42Z","timestamp":1791022602273,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.yrtph.2011.11.013","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T11:10:20Z","timestamp":1323601820000},"page":"74-84","source":"Crossref","is-referenced-by-count":20,"title":["In vitro enrofloxacin binding in human fecal slurries"],"prefix":"10.1016","volume":"62","author":[{"given":"Youngbeom","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean W.","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Veach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Steve Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hayd\u00e9e Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia A.","family":"Pineiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Cerniglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2011.11.013_b0005","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1128\/AEM.03032-05","article-title":"Transformation of the antibacterial agent norfloxacin by environmental Mycobacteria","volume":"72","author":"Adjei","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1139\/w06-101","article-title":"Acetylation and nitrosation of ciprofloxacin by environmental strains of Mycobacteria","volume":"53","author":"Adjei","year":"2007","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0015","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1128\/AEM.69.7.4159-4166.2003","article-title":"Reductive dehalogenation of brominated phenolic compounds by microorganisms associated with the marine sponge Aplysina aerophoba","volume":"69","author":"Ahn","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0020","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1897\/05-010R.1","article-title":"Co-amendment with halogenated compounds enhances anaerobic microbial dechlorination of 1,2,3,4-tetrachlorodibenzo-p-dioxin and 1,2,3,4-tetrachlorodibenzofuran in estuarine sediments","volume":"24","author":"Ahn","year":"2005","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.yrtph.2011.11.013_b0025","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"Backhed","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2011.11.013_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yrtph.2005.06.005","article-title":"Antibiotics in the human food chain: establishing no effect levels of tetracycline, neomycin, and erythromycin using a chemostat model of the human colonic microflora","volume":"43","author":"Carman","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/rtph.1999.1300","article-title":"Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora","volume":"29","author":"Cerniglia","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2885.2004.00595.x","article-title":"Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora","volume":"28","author":"Cerniglia","year":"2005","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2011.11.013_b0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.jim.2900409","article-title":"Microbial models of soil metabolism: biotransformations of danofloxacin","volume":"19","author":"Chen","year":"1997","journal-title":"J. Ind. Microbiol. Biot."},{"key":"10.1016\/j.yrtph.2011.11.013_b0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/bmc.900","article-title":"Monitoring of fluoroquinolone residual levels in chicken eggs by microbiological assay and confirmation by liquid chromatography","volume":"22","author":"Cho","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.yrtph.2011.11.013_b0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2180-10-101","article-title":"The analysis of oral microbial communities of wild-type and toll-like receptor 2-deficient mice using a 454 GS FLX Titanium pyrosequencer","volume":"10","author":"Chun","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0060","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1128\/AEM.71.10.6077-6085.2005","article-title":"Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans","volume":"71","author":"Clavel","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0065","unstructured":"Clinical and Laboratory Standards Institute. 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria isolated From Animals, Third Edition. Available from <http:\/\/www.clsi.org\/source\/orders\/free\/m31-a3.pdf>."},{"key":"10.1016\/j.yrtph.2011.11.013_b0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0009-8981(85)90244-X","article-title":"A new method for chemical-analysis of feces","volume":"150","author":"Costongs","year":"1985","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.yrtph.2011.11.013_b0075","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1021\/jf052445i","article-title":"Simultaneous determination of (Fluoro) quinolone antibiotics in kidney, marine products, eggs, and muscle by enzyme-linked immunosorbent assay (ELISA)","volume":"54","author":"Delahaut","year":"2006","journal-title":"J. Agri. Food Chem."},{"key":"10.1016\/j.yrtph.2011.11.013_b0080","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1371\/journal.pbio.0060280","article-title":"The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing","volume":"6","author":"Dethlefsen","year":"2008","journal-title":"Plos Biol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tree.2006.06.013","article-title":"Assembly of the human intestinal microbiota","volume":"21","author":"Dethlefsen","year":"2006","journal-title":"Trends Ecol. Evol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0090","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2011.11.013_b0095","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/AAC.32.12.1869","article-title":"Norfloxacin binds to human fecal material","volume":"32","author":"Edlund","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/34.1.127","article-title":"The relationship between an increase in beta-lactamase activity after oral-administration of 3 new cephalosporins and protection against intestinal ecological disturbances","volume":"34","author":"Edlund","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0105","unstructured":"EMA, 1998. The European Agency for the Evaluation of Medicinal products. Enrofloxacin (modification for bovine, porcine and poultry). EMEA\/MRL\/388\/98-Final. Available form: <www.ema.europa.eu\/pdfs\/vet\/mrls\/038898en.pdf>."},{"key":"10.1016\/j.yrtph.2011.11.013_b0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jac\/27.2.199","article-title":"Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary-medicine","volume":"27","author":"Endtz","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0115","series-title":"Evaluation of certain veterinary drug residues in food: Forty-eight Meeting of the Joint FAO\/WHO Expert Committee on Food Additives. WHO technical Report Series No. 39","year":"1997"},{"key":"10.1016\/j.yrtph.2011.11.013_b0120","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yrtph.2011.11.013_b0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MOG.0b013e3282f2b0e8","article-title":"Gastrointestinal microbiology enters the metagenomics era","volume":"24","author":"Frank","year":"2008","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0130","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2011.11.013_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/S0022172400060897","article-title":"Binding to and antibacterial effect of ampicillin, neomycin and polymyxin-B on human feces","volume":"93","author":"Hazenberg","year":"1984","journal-title":"J. Hyg."},{"key":"10.1016\/j.yrtph.2011.11.013_b0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00393668","article-title":"Binding to feces and influence on human anaerobes of anti-microbial agents used for selective decontamination","volume":"49","author":"Hazenberg","year":"1983","journal-title":"Antonie van Leeuwenhoek"},{"key":"10.1016\/j.yrtph.2011.11.013_b0145","doi-asserted-by":"crossref","first-page":"e1000255","DOI":"10.1371\/journal.pgen.1000255","article-title":"Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing","volume":"4","author":"Huse","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.yrtph.2011.11.013_b0150","unstructured":"International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. VICH Guideline 36 (2004) Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI."},{"key":"10.1016\/j.yrtph.2011.11.013_b0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01710684","article-title":"The non-enzymatic inactivation of thirteen beta-lactam antibiotics in human feces","volume":"20","author":"Jansen","year":"1992","journal-title":"Infection"},{"key":"10.1016\/j.yrtph.2011.11.013_b0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2672.2008.04026.x","article-title":"Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant","volume":"106","author":"Jung","year":"2009","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2885.1995.tb00604.x","article-title":"Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows","volume":"18","author":"Kaartinen","year":"1995","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.yrtph.2011.11.013_b0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.43.3.525","article-title":"Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin","volume":"43","author":"Kamberi","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0175","series-title":"Nucleic Acid Techniques in Bacterial Systematics","first-page":"115","article-title":"16S\/23S rRNA sequencing","author":"Lane","year":"1991"},{"key":"10.1016\/j.yrtph.2011.11.013_b0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.chroma.2006.11.068","article-title":"Determination of ofloxacin, norfloxacin, and ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography with fluorescence detection, and liquid chromatography\u2013tandem mass spectrometry","volume":"1139","author":"Lee","year":"2007","journal-title":"J Chromatogr. A"},{"key":"10.1016\/j.yrtph.2011.11.013_b0185","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/AAC.43.8.1988","article-title":"Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration","volume":"43","author":"McKellar","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0190","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/AAC.00915-06","article-title":"Prevalence in the United States of aac(6\u2032)-Ib-cr encoding a ciprofloxacin-modifying enzyme","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yrtph.2006.02.002","article-title":"Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model","volume":"45","author":"Perrin-Guyomard","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0200","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1053\/j.gastro.2009.01.072","article-title":"Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era","volume":"136","author":"Preidis","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yrtph.2011.11.013_b0205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000087253","article-title":"Evidence for active drug efflux in fluoroquinolone resistance in Clostridium hathewayi","volume":"51","author":"Rafii","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.yrtph.2011.11.013_b0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4315\/0362-028X-71.1.223","article-title":"Antibiotic residues distribute uniformly in broiler chicken breast muscle tissue","volume":"71","author":"Reyes-Herrera","year":"2008","journal-title":"J. Food Protect."},{"key":"10.1016\/j.yrtph.2011.11.013_b0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3382\/ps.2010-01057","article-title":"The relationship between blood and muscle samples to monitor for residues of the antibiotic enrofloxacin in chickens","volume":"90","author":"Reyes-Herrera","year":"2011","journal-title":"Poultry Sci."},{"key":"10.1016\/j.yrtph.2011.11.013_b0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.yrtph.2011.11.013_b0225","doi-asserted-by":"crossref","first-page":"e8230","DOI":"10.1371\/journal.pone.0008230","article-title":"A high-throughput DNA sequence aligner for microbial ecology studies","volume":"4","author":"Schloss","year":"2009","journal-title":"Plos One"},{"key":"10.1016\/j.yrtph.2011.11.013_b0230","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-2672.2007.03288.x","article-title":"Impact of antimicrobial residues on gut communities: are the new regulations effective?","volume":"102","author":"Silley","year":"2007","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0235","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijantimicag.2003.07.014","article-title":"A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces","volume":"23","author":"Sunderland","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.yrtph.2011.11.013_b0240","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0245","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1111\/j.1462-2920.2009.01982.x","article-title":"Towards the human intestinal microbiota phylogenetic core","volume":"11","author":"Tap","year":"2009","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0250","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0378-4347(00)82739-5","article-title":"High-performance liquid-chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue","volume":"493","author":"Tyczkowska","year":"1989","journal-title":"J. Chromatogr. Biomed."},{"issue":"146","key":"10.1016\/j.yrtph.2011.11.013_b0255","first-page":"44105","article-title":"Docket No. 2000N\u20131571, Enrofloxacin for poultry; final decision on withdrawal of new animal drug application following formal evidentiary public hearing; availability","volume":"70","year":"2005","journal-title":"Federal Register"},{"key":"10.1016\/j.yrtph.2011.11.013_b0260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/inf.1985.17.issue-3.09","article-title":"Influence of feces on the activity of antimicrobial agents used for decontamination of the alimentary canal","volume":"17","author":"van Saene","year":"1985","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.yrtph.2011.11.013_b0265","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jac\/14.6.605","article-title":"Biological inactivation by feces of antimicrobial drugs applicable in selective decontamination of the digestive tract","volume":"14","author":"Veringa","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0270","unstructured":"VICH (International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products) Steering Committee and Expert Working Group, 2011. Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. Available from <http:\/\/www.vichsec.org\/en\/GL36(R)-st4.doc>."},{"key":"10.1016\/j.yrtph.2011.11.013_b0275","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/AAC.6.4.415","article-title":"Binding of aminoglycosides to feces","volume":"6","author":"Wagman","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2011.11.013_b0280","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1111\/j.1462-2920.2008.01717.x","article-title":"The species composition of the human intestinal microbiota differs between particle-associated and liquid phase communities","volume":"10","author":"Walker","year":"2008","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.yrtph.2011.11.013_b0285","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0016-5085(95)90134-5","article-title":"Determinants of decreased fecal consistency in patients with diarrhea","volume":"108","author":"Wenzl","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yrtph.2011.11.013_b0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2885.2002.00430.x","article-title":"Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations","volume":"25","author":"Wiuff","year":"2002","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.yrtph.2011.11.013_b0295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2885.1998.00108.x","article-title":"The use of microbiological end-points in the safety evaluation and elaboration of maximum residue limits for veterinary drugs intended for use in food producing animals","volume":"21","author":"Woodward","year":"1998","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.yrtph.2011.11.013_b0300","unstructured":"World Health Organization. 1998. Use of quinolones in food animals and potential impact on human health. Report of WHO Meeting, Geneva, Switzerland. Available from: <http:\/\/whqlibdoc.who.int\/hq\/1998\/WHO_EMC_ZDI_98.10.pdf>."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001100242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001100242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T19:04:11Z","timestamp":1561057451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323001100242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S027323001100242X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2011.11.013","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}